Abstract:Pharmaceuticals are of concern to our planet and health as they can accumulate in the environment. The impact of these biologically active compounds on ecosystems is hard to predict, and information on their biodegradation is necessary to establish sound risk assessment. Microbial communities are promising candidates for the biodegradation of pharmaceuticals such as ibuprofen, but little is known yet about their degradation capacity of multiple micropollutants at higher concentrations (100 mg/L). In this work, microbial communities were cultivated in lab-scale membrane bioreactors (MBRs) exposed to increasing concentrations of a mixture of six micropollutants (ibuprofen, diclofenac, enalapril, caffeine, atenolol, paracetamol). Key players of biodegradation were identified using a combinatorial approach of 16S rRNA sequencing and analytics. Microbial community structure changed with increasing pharmaceutical intake (from 1 to 100 mg/L) and reached a steady-state during incubation for 7 weeks on 100 mg/L. HPLC analysis revealed a fluctuating but significant degradation (30-100%) of five pollutants (caffeine, paracetamol, ibuprofen, atenolol, enalapril) by an established and stable microbial community mainly composed of Achromobacter, Cupriavidus, Pseudomonas and Leucobacter. By using the microbial community from MBR1 as inoculum for further batch culture experiments on single micropollutants (400 mg/L substrate, respectively), different active microbial consortia were obtained for each single micropollutant. Microbial genera potentially responsible for degradation of the respective micropollutant were identified, i.e. Pseudomonas sp. and Sphingobacterium sp. for ibuprofen, caffeine and paracetamol, Sphingomonas sp. for atenolol and Klebsiella sp. for enalapril. Our study demonstrates the feasibility of cultivating stable microbial communities capable of degrading simultaneously a mixture of highly concentrated pharmaceuticals in lab-scale MBRs and the identification of microbial genera potentially responsible for the degradation of specific pollutants. KEY POINTS: • Multiple pharmaceuticals were removed by stable microbial communities. • Microbial key players of five main pharmaceuticals were identified.

Neutral proteases of human granulocytes. III. Interaction between human granulocyte elastase and plasma protease inhibitors.

Primary culture of rat thymic non-lymphoid cells: influence of culture time on the expression of macrophage differentiation antigens defined by monoclonal antibodies.

Biological Phosphorus Removal from Real Wastewater in a Sequencing Batch Reactor Operated As Aerobic/extended-Idle Regime

Tracing pharmaceuticals in a municipal plant for integrated wastewater and organic solid waste treatment

Feasibility of anaerobic packed and structured-bed reactors for sulfamethoxazole and ciprofloxacin removal from domestic sewage

Simultaneous Removal of Organic Matter and Nutrients from High Strength Organic Wastewater Using Sequencing Batch Reactor (SBR)

Organic and nutrient removal for domestic wastewater treatment using bench-scale sequencing batch reactor

Biological treatment of ranitidine and cefixime trihydrate mixed solution by activated sludge in sequencing batch reactor

What price reproductive potential?

Removal of 17α-ethinylestradiol and total phosphorus in a sequencing batch reactor under two different sludge retention-time conditions

Combined use of strictly anaerobic MBBR and aerobic MBR for municipal wastewater treatment and removal of pharmaceuticals

Analyzing microbial communities and their biodegradation of multiple pharmaceuticals in membrane bioreactors

Partial Nitrification and Enhanced Biological Phosphorus Removal in a Sequencing Batch Reactor Treating High-Strength Wastewater

Immune activation by histones: Plusses and minuses in inflammation

POSTTREATMENT OF EFFLUENT FROM COKE-PLANT WASTEWATER TREATMENT SYSTEM IN SEQUENCING BATCH REACTORS

Management of chronic pain in general practice.

Removal of emerging micropollutants from nanofiltration retentate of municipal wastewater within biological fixed‐bed reactors under nitrifying and denitrifying conditions

Effects of High Pharmaceutical Concentrations in Domestic Wastewater on Membrane Bioreactor Treatment Systems: Performance and Microbial Community

Biological treatment of benzophenone-type UV filter wastewater in a sequencing batch reactor (SBR)

Fate of beta blockers in aquatic-sediment systems: sorption and biotransformation

Biodegradation of glucose and paracetamol and process optimisation with open mixed microbial cultures in lab-scale sequencing batch reactors